Recent studies have shown that OPG inhibits cancer-induced osteoclastogenesis and prevents tumour growth in bone (Morony et al, 2001; Zhang et al, 2001), suggesting that tumour cells use the RANKL : RANK axis to induce osteolysis. The gene discussed is TNFRSF11A; the disease is neoplasm.